SARS-CoV-2 Mpro-IN-25
SARS-CoV-2 Mpro-IN-25 (Compound 3a) is a SARS-CoV-2 protease inhibitor with an IC50 value of 0.26 μM. SARS-CoV-2 Mpro-IN-25 exhibits antiviral activity and can be used in pneumonia-related research[1].
Product Specifications
CAS Number
2205006-23-9
UNSPSC
12352005
Target
Virus Protease
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-mpro-in-25.html
Smiles
O=C(C1=CC(O)=C(C(O)=C1)O)NC2=CC=C(C=C2)F
Molecular Formula
C13H10FNO4
Molecular Weight
263.22
References & Citations
[1]de Carvalho MAG, et al. Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS-CoV-2 main protease. Arch Pharm (Weinheim) . 2024 Aug 15:e2400253.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040994-100 1x 100 µL
TNF alpha (J2D10), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680460-500 1x 500 µL
CD44 Standard (156-3C11), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681857-500 1x 500 µL
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details